Does LEUPROLIDE Cause Metastases to lung? 176 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Metastases to lung have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.3% of all adverse event reports for LEUPROLIDE.
176
Reports of Metastases to lung with LEUPROLIDE
0.3%
of all LEUPROLIDE reports
55
Deaths
26
Hospitalizations
How Dangerous Is Metastases to lung From LEUPROLIDE?
Of the 176 reports, 55 (31.3%) resulted in death, 26 (14.8%) required hospitalization, and 8 (4.5%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEUPROLIDE. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
Which LEUPROLIDE Alternatives Have Lower Metastases to lung Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM